Genenta Science S.p.A GNTA
NASDAQ GNTA
$0.80 +0.10 (+14.80%)
At close: Oct 1, 2026 · 4:00 PM EDT

Genenta Science S.p.A (GNTA) Capital Expenditures (2020 - 2022)

Updated

Genenta Science S.p.A's Capital Expenditures was -$8,615 in the year ended Dec 31, 2025, compared with -$4,774 a year earlier.

Analysis

Genenta Science S.p.A (GNTA) Capital Expenditures (2020 - 2022) Analysis & Trends

From the year ended Dec 31, 2020 onward, Genenta Science S.p.A has reported Capital Expenditures for 6 years.

  • Annual Capital Expenditures has moved between -$27,618 (the year ended Dec 31, 2022) and -$4,774 (the year ended Dec 31, 2024) over five years.
  • Per Business Quant data, Capital Expenditures in earlier years was -$4,774 in the year ended Dec 31, 2024, -$14,838 in the year ended Dec 31, 2023, -$27,618 in the year ended Dec 31, 2022 and -$10,306 in the year ended Dec 31, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.32 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 322.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -763.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 140.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 112.20 Mn
10 Genenta Science S.p.A 16.40 Mn 16.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -27,618.10
Dec 31, 2021 -10,306.03
Dec 31, 2020 -24,884.28
API Access

Genenta Science S.p.A Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=GNTA&period=max&api_key=YOUR_API_KEY